首页> 外文OA文献 >P1.01-53 Clinical Utility of Two Different Plasma-Based EGFR Mutation Tests in Patients with Advanced Non-Small Cell Lung Cancer

【2h】

P1.01-53 Clinical Utility of Two Different Plasma-Based EGFR Mutation Tests in Patients with Advanced Non-Small Cell Lung Cancer

机译：P1.01-53晚期非小细胞肺癌患者患有两种不同血浆EGFR突变试验的临床效用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Lee; K. Lee; S. Lim; M. Kwon; H. Park; H. Woo;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. EGFR敏感突变的晚期非小细胞肺癌患者EGFR-TKIs原发性耐药相关基因突变分析 [J] . 王芳, 刁夏尧, 张晓, 癌症（英文版） . 2020,第009期
2. MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria [J] . L. Barrera, J.R. Borbolla-Escoboza, E. Montes-Servin, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：MA 12.10血浆EGFR T790M突变检测在先进的非小细胞肺癌患者中的临床效用，根据Recist标准
3. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test [J] . Choi Moon Ki, Hong Jung Yong, Chang Won Jin, Cancer chemotherapy and pharmacology. . 2015,第6期

机译：吉非替尼单药II期治疗未治疗EGFR突变的晚期非小细胞肺癌预治疗患者的II期试验：敏感的EGFR突变试验的意义
4. Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations [J] . Minghui Zhang, Mingyang Liu, Yan Wang Journal of Thoracic Disease . 2016,第10期

机译：EGFR-TKI与患有EGFR突变的晚期非小细胞肺癌患者化疗组合的临床疗效
5. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
6. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
7. Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations [O] . Minghui Zhang, Mingyang Liu, Yan Wang 2016

机译：EGFR-TKIs联合化学疗法治疗携带EGFR突变的晚期非小细胞肺癌的临床疗效
8. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea. [O] . Eun-A Lim, Haeyoung Lee, Eunmi Bae, 2016

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗伴随诊断检测的经济学评价。

P1.01-53 Clinical Utility of Two Different Plasma-Based EGFR Mutation Tests in Patients with Advanced Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅